STI Stock Trade Intelligence
BLS

BLS Pharmaceuticals Ltd

Consumer Staples · ASX:BLS
$0.8950
▲ +4.68%
Market cap
$211M
Turnover
$148,200
Last price
$0.8950
Day change
+4.68%
Announcements
9
Range, past year
Open 0.970 · Low 0.775 · Now 0.895 · High 1.295
Open BLS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

BLS momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
17/100
Wyckoff phase
Accumulation29d
Trend stage
Distribution
1 Day
+4.7%
1 Week
+1.7%
1 Month
-19.4%
RSI
42
Avg daily range
5.5%

BLS Pharmaceuticals Ltd scores 17 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Distribution.

On the Wyckoff cycle it sits in Accumulation, where it has been for 29 trading days. The weekly timeframe reads Accumulation, which agrees with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -33.7%
  • Risk rating: Very High
  • Composite downside risk elevated
BLS appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

BLS announcements

Recent price-sensitive releases.
  • 2026-10-21 Q1 FY2027 Quarterly Activities Update Commitments Test Entity - First Quarter Activity Report | Company Presentation
  • 2026-10-15 BLS Quarterly Activities Report September 2026 Revised Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
  • 2026-10-15 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
  • 2026-08-31 BLS FY2027 Guidance Profit Guidance | Preliminary Final Report
  • 2026-08-31 BLS Investor Presentation Company Presentation | Preliminary Final Report
  • 2026-08-31 BLS FY2026 Results Announcement Web Cast | Preliminary Final Report
  • 2026-08-31 Annual Report to shareholders Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.